4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-22-043765
Chief Financial Officer acquired 39,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Silberman David Chief Financial Officer | 2022-07-28 | Grant or award | +39,000 | 108,000 | D |
Loading xslF345X03/doc4.xml…